TFBS Bioscience Inc. (6939.TWO)
Taipei Exchange · TWD · Healthcare · Diagnostics & Research
NT$17.90 (-4.79%) as of
Key statistics
- Market cap
- 633.38M
- EPS (TTM)
- -1.88
- Dividend yield
- 0.00%
- 52-week range
- 17.90 – 27.85
- Profit margin
- 0.00%
- Volume
- 20.09k
About TFBS Bioscience Inc.
TFBS Bioscience Inc., a contract research organization, provides biological testing services in Taiwan. It offers viral vector manufacturing services for cell and gene therapy products; and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products. The company was incorporated in 2016 and is headquartered in New Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- New Taipei City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.